OPERF
Oregon Public Employees Retirement Fund Portfolio holdings
AUM
$5.67B
1-Year Return
21.63%
This Quarter Return
+4.13%
1 Year Return
+21.63%
3 Year Return
+90.63%
5 Year Return
+181.52%
10 Year Return
+432.56%
AUM
$7.35B
AUM Growth
+$298M
(+4.2%)
Cap. Flow
+$74.9M
Cap. Flow
% of AUM
1.02%
Top 10 Holdings %
Top 10 Hldgs %
16.84%
Holding
1,707
New
62
Increased
1,309
Reduced
285
Closed
39
Top Buys
| 1 |
Mastercard
MA
|
+$44.6M |
| 2 |
Visa
V
|
+$21.6M |
| 3 |
Danaher
DHR
|
+$19M |
| 4 |
Broadcom
AVGO
|
+$17.7M |
| 5 |
Honeywell
HON
|
+$16.9M |
Top Sells
| 1 |
Pfizer
PFE
|
+$40.9M |
| 2 |
Johnson & Johnson
JNJ
|
+$34.9M |
| 3 |
Verizon
VZ
|
+$30.6M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$30.2M |
| 5 |
Coca-Cola
KO
|
+$22.9M |
Sector Composition
| 1 | Technology | 20.3% |
| 2 | Financials | 13.63% |
| 3 | Healthcare | 12.53% |
| 4 | Industrials | 9.88% |
| 5 | Consumer Discretionary | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
451
Gentex
GNTX
$6.19B
| $2.58M | 0.04% |
104,669
-1,865
| -2% | -$45.9K |
|
|
CDK
452
DELISTED
CDK Global, Inc.
CDK
| $2.57M | 0.03% |
51,977
+713
| +1% | +$35.3K |
|
453
Bio-Rad Laboratories Class A
BIO
$7.74B
| $2.57M | 0.03% |
8,212
+215
| +3% | +$67.2K |
|
454
Corpay
CPAY
$22.1B
| $2.56M | 0.03% |
9,129
-151
| -2% | -$42.4K |
|
|
EV
455
DELISTED
Eaton Vance Corp.
EV
| $2.56M | 0.03% |
59,432
-3,188
| -5% | -$137K |
|
456
Zimmer Biomet
ZBH
$20.6B
| $2.56M | 0.03% |
22,378
+347
| +2% | +$39.7K |
|
|
ACC
457
DELISTED
American Campus Communities, Inc.
ACC
| $2.56M | 0.03% |
55,422
+545
| +1% | +$25.2K |
|
458
Woodward
WWD
$14.2B
| $2.56M | 0.03% |
22,587
+319
| +1% | +$36.1K |
|
459
Douglas Emmett
DEI
$2.7B
| $2.56M | 0.03% |
64,138
+924
| +1% | +$36.8K |
|
460
Fortive
FTV
$16.1B
| $2.55M | 0.03% |
37,432
+600
| +2% | +$40.9K |
|
461
Erie Indemnity
ERIE
$17.3B
| $2.54M | 0.03% |
+10,000
| New | +$2.54M |
|
462
Encompass Health
EHC
$12.6B
| $2.54M | 0.03% |
50,414
+708
| +1% | +$35.7K |
|
463
Baker Hughes
BKR
$44.8B
| $2.53M | 0.03% |
102,562
+49,641
| +94% | +$1.22M |
|
464
M&T Bank
MTB
$31.2B
| $2.52M | 0.03% |
14,818
+86
| +0.6% | +$14.6K |
|
465
Pinnacle West Capital
PNW
$10.4B
| $2.51M | 0.03% |
26,672
+4,350
| +19% | +$409K |
|
466
Unum
UNM
$12.5B
| $2.51M | 0.03% |
74,719
+2,134
| +3% | +$71.6K |
|
467
HF Sinclair
DINO
$9.81B
| $2.5M | 0.03% |
54,040
+1,898
| +4% | +$87.8K |
|
468
First Financial Bankshares
FFIN
$5.13B
| $2.49M | 0.03% |
80,776
-18,680
| -19% | -$575K |
|
469
Idexx Laboratories
IDXX
$52.5B
| $2.49M | 0.03% |
9,024
+54
| +0.6% | +$14.9K |
|
470
Haemonetics
HAE
$2.61B
| $2.48M | 0.03% |
20,623
+34
| +0.2% | +$4.09K |
|
471
Vistra
VST
$65.7B
| $2.48M | 0.03% |
109,563
-15,300
| -12% | -$346K |
|
472
Sabre
SABR
$698M
| $2.47M | 0.03% |
111,287
+1,574
| +1% | +$34.9K |
|
|
PS
473
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
| $2.47M | 0.03% |
81,317
+43,875
| +117% | +$1.33M |
|
|
AMED
474
DELISTED
Amedisys
AMED
| $2.46M | 0.03% |
20,278
-333
| -2% | -$40.4K |
|
475
Marvell Technology
MRVL
$57.6B
| $2.46M | 0.03% |
103,146
-23,600
| -19% | -$563K |
|